amantadine has been researched along with Nervous System Diseases in 14 studies
amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source
Nervous System Diseases: Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amantadine hydrochloride has been reported efficacious in the symptomatic management of patients with multiple sclerosis (MS)." | 5.27 | Failure of amantadine hydrochloride to alter immune responses in the experimental allergic encephalomyelitis model of neuroautoimmune disease. ( Awerbuch, G; Sandyk, R; Subramanian, G, 1988) |
| " A literature review about the spectrum of differential diagnosis in patients with livedo reticularis (especially cutis marmorata and amantadine-induced livedo reticularis) and livedo racemosa (especially Sneddon's syndrome, Divry-van Bogaert syndrome, systemic lupus erythematosus, antiphospholipid antibody syndrome, polyarteritis nodosa, cholesterol embolization syndrome, livedoid vasculopathy and haematological diseases) is provided." | 4.82 | The spectrum of differential diagnosis in neurological patients with livedo reticularis and livedo racemosa. A literature review. ( Berlit, P; Kraemer, M; Linden, D, 2005) |
| "The study sample consisted of 15 cancer patients with the diagnosis of surgical neuropathic pain." | 2.69 | The NMDA receptor antagonist amantadine reduces surgical neuropathic pain in cancer patients: a double blind, randomized, placebo controlled trial. ( Adler, R; Eisenberg, E; Fried, G; Pud, D; Spitzer, A; Yarnitsky, D, 1998) |
| "　The anti-influenza virus drug oseltamivir has been reported to have several pharmacological actions including blocking of nicotinic acetylcholine receptor channels and activation of the dopaminergic system." | 1.48 | [Similarity of Clinically Significant Neuropsychiatric Adverse Reactions Listed in Package Inserts between the Anti-influenza Drugs Oseltamivir and Amantadine (Possibility Attributable to Common Pharmacological Effects)]. ( Fukushima, A; Okamura, M; Ono, H, 2018) |
| "Neurobehavioural sequelae of traumatic brain injuries require an appropriate/effective pharmacological response in that they represent an important cause of disability." | 1.35 | Pharmacological treatment of neurobehavioural sequelae of traumatic brain injury. ( Lombardi, F, 2008) |
| " We studied the severity of illness due to influenza among adults residing in a center for the developmentally disabled and assessed adverse reactions to amantadine and oseltamivir prophylaxis." | 1.32 | Adverse effects of amantadine and oseltamivir used during respiratory outbreaks in a center for developmentally disabled adults. ( Benjamin, JH; Gardner, C; Green, K; Lee, W; Loeb, M; McArthur, M; McGeer, AJ; Simor, AE, 2004) |
| "Amantadine hydrochloride has been reported efficacious in the symptomatic management of patients with multiple sclerosis (MS)." | 1.27 | Failure of amantadine hydrochloride to alter immune responses in the experimental allergic encephalomyelitis model of neuroautoimmune disease. ( Awerbuch, G; Sandyk, R; Subramanian, G, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (42.86) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 2 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ono, H | 1 |
| Okamura, M | 1 |
| Fukushima, A | 1 |
| Zubair, UB | 1 |
| Majid, H | 1 |
| McGeer, AJ | 1 |
| Lee, W | 1 |
| Loeb, M | 1 |
| Simor, AE | 1 |
| McArthur, M | 1 |
| Green, K | 1 |
| Benjamin, JH | 1 |
| Gardner, C | 1 |
| Kraemer, M | 1 |
| Linden, D | 1 |
| Berlit, P | 1 |
| Lombardi, F | 1 |
| Tilley, JW | 1 |
| Kramer, MJ | 1 |
| Wenk, GL | 1 |
| Danysz, W | 1 |
| Mobley, SL | 1 |
| Pud, D | 1 |
| Eisenberg, E | 1 |
| Spitzer, A | 1 |
| Adler, R | 1 |
| Fried, G | 1 |
| Yarnitsky, D | 1 |
| Taira, T | 1 |
| Greer, M | 1 |
| Gehlen, W | 1 |
| Sandyk, R | 1 |
| Awerbuch, G | 1 |
| Subramanian, G | 1 |
| Kytomaki, O | 1 |
| Nousiainen, R | 1 |
| Pekkarinen, A | 1 |
| Rinne, U | 1 |
| Siirtola, T | 1 |
| Sonninen, V | 1 |
| Viljanen, M | 1 |
| Potvin, AR | 1 |
| Albers, JW | 1 |
| Repa, BS | 1 |
| Henderson, WG | 1 |
| Walker, JE | 1 |
| Stribley, RF | 1 |
| Tourtellotte, WW | 1 |
4 reviews available for amantadine and Nervous System Diseases
| Article | Year |
|---|---|
The spectrum of differential diagnosis in neurological patients with livedo reticularis and livedo racemosa. A literature review.
Topics: Adolescent; Adult; Amantadine; Autoantibodies; Cerebrovascular Disorders; Diagnosis, Differential; F | 2005 |
Aminoadamantane derivatives.
Topics: Amantadine; Animals; Antiviral Agents; Humans; Memantine; Nervous System Diseases; Rimantadine | 1981 |
[Iatrogenic damage possibilities in the drug therapy of neurologic and psychiatric diseases].
Topics: Amantadine; Anticonvulsants; Barbiturates; Benzodiazepines; Carbamazepine; Central Nervous System Di | 1977 |
Quantitative evaluation of neuropharmacological trials.
Topics: Activities of Daily Living; Age Factors; Amantadine; Clinical Trials as Topic; Dihydroxyphenylalanin | 1974 |
2 trials available for amantadine and Nervous System Diseases
| Article | Year |
|---|---|
The NMDA receptor antagonist amantadine reduces surgical neuropathic pain in cancer patients: a double blind, randomized, placebo controlled trial.
Topics: Adult; Aged; Amantadine; Analgesics, Non-Narcotic; Double-Blind Method; Female; Hot Temperature; Hum | 1998 |
Quantitative evaluation of neuropharmacological trials.
Topics: Activities of Daily Living; Age Factors; Amantadine; Clinical Trials as Topic; Dihydroxyphenylalanin | 1974 |
9 other studies available for amantadine and Nervous System Diseases
| Article | Year |
|---|---|
[Similarity of Clinically Significant Neuropsychiatric Adverse Reactions Listed in Package Inserts between the Anti-influenza Drugs Oseltamivir and Amantadine (Possibility Attributable to Common Pharmacological Effects)].
Topics: Amantadine; Antiviral Agents; Dopamine Agonists; Drug Labeling; Enzyme Inhibitors; Humans; Influenza | 2018 |
Anti-NMDA Receptor Encephalitis in a Young Girl with Altered Behaviour and Abnormal Movements.
Topics: Adolescent; Amantadine; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Autoantibodies; Bromocripti | 2018 |
Adverse effects of amantadine and oseltamivir used during respiratory outbreaks in a center for developmentally disabled adults.
Topics: Acetamides; Adult; Aged; Amantadine; Antiviral Agents; Child; Comorbidity; Developmental Disabilitie | 2004 |
Pharmacological treatment of neurobehavioural sequelae of traumatic brain injury.
Topics: Amantadine; Animals; Antidepressive Agents; Antipsychotic Agents; Brain Injuries; Cognition; Cogniti | 2008 |
MK-801, memantine and amantadine show neuroprotective activity in the nucleus basalis magnocellularis.
Topics: Amantadine; Animals; Basal Ganglia; Cerebral Cortex; Choline O-Acetyltransferase; Dizocilpine Maleat | 1995 |
Comments on Eisenberg and Pud, PAIN, 74 (1998) 337-339.
Topics: Amantadine; Analgesics, Non-Narcotic; Humans; Nervous System Diseases; Pain | 1998 |
How to achieve maximum benefit for the patient with Parkinson's disease.
Topics: Aged; Amantadine; Carbidopa; Diagnosis, Differential; Histamine H1 Antagonists; Humans; Levodopa; Ne | 1976 |
Failure of amantadine hydrochloride to alter immune responses in the experimental allergic encephalomyelitis model of neuroautoimmune disease.
Topics: Amantadine; Animals; Antibody Formation; Autoimmune Diseases; Encephalomyelitis, Autoimmune, Experim | 1988 |
Effects of L-dopa on plasma growth hormones and insulin.
Topics: Administration, Oral; Amantadine; Blood Glucose; Dihydroxyphenylalanine; Growth Hormone; Humans; Inj | 1972 |